文献速递急性肾损伤慢性肾脏病

停还是不停,这是个问题:将病日用药指导纳入常规照护

To Hold or Not to Hold, That Is the Question: Sick Day Medication Guidance as Routine Care.
PubMed 文献 · Am J Kidney Dis · 2026-06-19

本文为观点性文章,讨论在SGLT2抑制剂、RAAS抑制剂和MRA等具有心肾保护作用的药物广泛联合使用的背景下,病日用药指导(sick-day medication guidance)尚未被临床普遍采纳。文章分析了反对常规使用该指导的多种顾虑,并论证病日用药指导是降低AKI风险及其相关费用、促进这些重要药物更持续使用的有价值工具。

要点

  • SGLT2抑制剂、RAAS抑制剂和MRA联合使用增多,容量不足和相对低血压时AKI风险升高。
  • 病日用药指导建议在疾病期间暂停相关药物以降低AKI风险,但临床采纳不广泛。
  • 作者认为病日用药指导可减少AKI风险与费用,并促进重要药物的持续使用。

核心结论

  • 病日用药指导是向患者宣教心肾保护药物使用的有价值工具,可降低AKI风险及相关费用,并最终促进这些重要药物更持续地使用。

研究设计与样本

  • 本文为观点性文章(perspective),未报告系统检索范围或样本量。

主要发现

  • SGLT2抑制剂、RAAS抑制剂和MRA的启用率及联合使用率增加。
  • 这些药物降低肾小球内高压和血压的机制,在容量不足和相对低血压时限制了维持肾脏灌注的能力,从而增加AKI发生风险及AKI严重程度。
  • 病日用药指导尚未被执业者广泛采纳。

关键数值与推荐

  • 原文未报告病日的具体定义标准、停药时长或恢复用药时机。

临床怎么用

  • 可考虑将病日用药指导作为常规照护的一部分,用于向使用SGLT2抑制剂、RAAS抑制剂和MRA的患者进行用药宣教。

局限性

  • 原文提及缺乏证明停药获益的数据。
  • 原文提及对病日定义标准的困惑、停药时长和恢复时机不明确。
  • 原文提及担心该信息导致患者对用药犹豫,以及担心因频繁中断而失去这些药物的治疗获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With the demonstrated cardiovascular- and kidney-protective benefits of medications such as sodium/glucose cotransporter 2 inhibitors, renin-angiotensin-aldosterone system inhibitors, and mineralocorticoid receptor antagonists, there are increased rates of initiation and use of combinations of these agents. The same mechanisms that allow for the reduction of glomerular hypertension and blood pressure limit the ability to maintain kidney perfusion in the setting of volume depletion and relative hypotension and, as a result, increase the risk of development of acute kidney injury (AKI) and the severity of AKI. "Sick-day" medication guidance that provides recommendations for holding medications in the setting of illness to mitigate the risk of AKI has not been widely adopted by practitioners. Confusion regarding the criteria to define a sick day, lack of clarity as to how long to hold the medications and when to resume treatment, concerns that this information drives patient hesitancy to use the medications, lack of data demonstrating the benefit of holding medication, and concerns that patients will lose out on the therapeutic benefits of these agents as a result of constant interruption have fueled arguments against the regular use of these sick-day medication guidelines. In this perspective, sick-day medication guidance will be shown to be a valuable tool in counseling patients about the use of medications that reduces the risk of and costs associated with an AKI episode and ultimately promotes more consistent use of these important medications.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Thavarajah S. To Hold or Not to Hold, That Is the Question: Sick Day Medication Guidance as Routine Care. Am J Kidney Dis. 2026. PMID: 42320577. doi:10.1053/j.ajkd.2026.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。